Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Soleno Therapeutics (SLNO) EBT Margin (2016 - 2017)

Historic EBT Margin for Soleno Therapeutics (SLNO) over the last 5 years, with Q2 2017 value amounting to 296500.0%.

  • Soleno Therapeutics' EBT Margin fell 1817500000.0% to 296500.0% in Q2 2017 from the same period last year, while for Dec 2017 it was 4572.56%, marking a year-over-year decrease of 35969300.0%. This contributed to the annual value of 76125.54% for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q2 2017, Soleno Therapeutics' EBT Margin is 296500.0%, which was down 1817500000.0% from 517.74% recorded in Q1 2017.
  • Over the past 5 years, Soleno Therapeutics' EBT Margin peaked at 295.07% during Q2 2014, and registered a low of 296500.0% during Q2 2017.
  • Moreover, its 5-year median value for EBT Margin was 645.95% (2016), whereas its average is 28638.35%.
  • Its EBT Margin has fluctuated over the past 5 years, first soared by 100781300bps in 2016, then crashed by -1817500000bps in 2017.
  • Soleno Therapeutics' EBT Margin (Quarter) stood at 273.91% in 2013, then tumbled by -34bps to 179.54% in 2014, then tumbled by -909bps to 1451.82% in 2015, then surged by 56bps to 645.95% in 2016, then plummeted by -45802bps to 296500.0% in 2017.
  • Its EBT Margin stands at 296500.0% for Q2 2017, versus 517.74% for Q1 2017 and 645.95% for Q4 2016.